Aug 10, 2023

Nanobodies inhibit SARS-CoV-2 infection, including emergent variants

Posted by in category: biotech/medical

Australian researchers have identified neutralizing nanobodies that block the SARS-CoV-2 virus from entering cells in preclinical models.

The discovery paves the way for further investigations into nanobody-based treatments for COVID-19.

Published in PNAS, the research is part of a consortium-led effort, bringing together the expertise of Australian academic leaders in and antibody therapeutics at WEHI, the Doherty Institute and the Kirby Institute.

Leave a reply